
Anixa Biosciences Investor Relations Material
Latest events

Status Update
Anixa Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Anixa Biosciences Inc
Access all reports
Anixa Biosciences Inc is a biotechnology company focused on developing therapies and vaccines for cancer and infectious diseases. The company pursues programs in immunotherapy, cancer vaccines, and antiviral therapies through research partnerships and internal development. Anixa Biosciences operates in the early-stage biotechnology sector. The company is headquartered in San Jose, California, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
ANIX
Country
🇺🇸 United States